Investors Grab CLVS Even Cheaper Than Its Secondary Stock Offering
July 18, 2017 at 10:01 AM EDT
Looking back to 28 days ago, Clovis Oncology Inc (CLVS) priced a 3,409,091 share secondary stock offering at $88.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..